Ovid Therapeutics, Inc. (OVID)
1.625
+0.06
(+3.50%)
USD |
NASDAQ |
Dec 10, 16:00
1.625
0.00 (0.00%)
After-Hours: 16:53
Ovid Therapeutics EPS Diluted (Quarterly): -0.171 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AnaptysBio, Inc. | 0.5208 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| MannKind Corp. | 0.0256 |
| Cassava Sciences, Inc. | -0.2237 |
| Cidara Therapeutics, Inc. | -3.096 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.16M |
| Revenue (Quarterly) | 0.132M |
| Total Expenses (Quarterly) | 12.29M |
| Enterprise Value | 99.96M |
| Gross Profit Margin (Quarterly) | 87.12% |
| Profit Margin (Quarterly) | -9.21K% |
| Earnings Yield | -31.46% |
| Normalized Earnings Yield | -28.51 |